Langzeitresultate Und Komplikationen Nach Einer Epistaxisbehandlung
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Nosebleed (Epistaxis) - Posterior or Anterior
- Sponsor
- University of Zurich
- Enrollment
- 591
- Locations
- 1
- Primary Endpoint
- Number of patients without recurrence
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
The aim of this study is to find the most agreeable and in the long term most efficient treatment for epistaxis.
Detailed Description
In the general population epistaxis occurs quite frequently. Approximately 60% of persons will be affected once in their lifetime, and 6% thereof will seek medical advice. Thereby anterior and posterior epistaxis are discerned. Anterior epistaxis is usually located at the Locus Kisselbachii, while posterior bleeds are found further back in the nose. There, most bleeds will originate from the A. sphenopalatina or the A. ethmoidalis. Different treatment modalities exist. Anterior epistaxis are usually easier to treat than posterior ones. The aim of this study is to find the most efficient treatment. This involves the assessment of long term results and potential sequelae. Existing data will be complemented with information about recurrences and complications. The question is: Which treatment method leads to the least numbers of recurrences in the long term with the fewest long term sequelae? Secondly, the most agreeable, least painful treatment method is to be identified. Therefore we will send out questionnaires to patients that were treated between March 29, 2007 and April 1st, 2008 at the Zurich University Hospital.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients treated during the study period with known address and who did not decease in the meantime.
Exclusion Criteria
- •Insufficiently filled out questionnaires; Obvious lack of ability to remember (as tested by control questions); Known mental disability
Outcomes
Primary Outcomes
Number of patients without recurrence
Time Frame: Up to 8 years post-treatment
Secondary Outcomes
- Discomfort caused by treatment(Up to 1 day post-treatment)